BPC-157 Arginate Research Reference

Catalog classification, reference sizes, lab math links, and source-backed data. Educational use only — not medical advice.

Researched for: BPC salt stability and formulation

Structural Research peptide PowderCapsule verified

Also known as: BPC-157 arginate salt, BPC arginate

Open in Calculator ← Compound Index All Tools

Quick Facts

Reference Sizes

250 ug x 60 capsules, 500 ug x 50 capsules, 500 ug x 60 capsules, 10 mg RUO vial

Storage

Use the lot-specific label and COA; no independently validated universal post-reconstitution condition exists

Solubility

Salt-specific; comparative stability and solubility claims are not independently established in peer-reviewed studies

Catalog Description

BPC-157 arginate is marketed as an arginine salt of the BPC-157 peptide, often under names such as stable BPC or pentadeca arginate. Peer-reviewed evidence does not establish that the marketed salt has superior oral bioavailability or clinical efficacy. Human evidence for BPC-157 itself is extremely limited, and the arginate-specific claims rely mainly on patents, supplier assertions, and extrapolation from other BPC-157 forms.

Catalog descriptions reflect research context only. Not a medical claim or treatment recommendation.

Research Profile

Half-Life

Arginate-specific human pharmacokinetics are unknown

Onset

Not established

Administration Routes (Research)

Oral (marketed format)Laboratory use

Reported Research Effects

Salt-form and formulation claims remain unverified in humans
Parent-peptide preclinical findings cannot establish arginate-specific efficacy
No arginate-specific randomized human trial

Reported Research Side Effects

No arginate-specific human safety profile
Product identity may not be distinguished by a generic purity chromatogram
Unapproved product and formulation-quality risk

Data source: FDA BPC-157 assessment, recent review, patent/vendor evidence, and community market checks

Reflects preclinical/research literature context only. Not a medical claim, dosing instruction, or treatment recommendation.

Research Protocols Reported in the Literature

No peer-reviewed arginate-specific human dose is established [Oral or laboratory use; Not established; Not established]Source: literature and regulatory evidence gap
250-500 ug/day [Oral; Variable; Daily]Source: community and vendor-reported only; not a validated protocol

Research Notes

The prior 100 mg to 1 g pack sizes were not representative. Current oral products are usually 250-500 ug per capsule in 50- or 60-count bottles; niche RUO vials are commonly 10 mg. Human-use and oral-superiority claims remain unverified.

Supplementary research context only. Not medical advice or a treatment recommendation.

Sources

FDA briefing document for BPC-157-related bulk substances — U.S. Food and Drug Administration
https://www.fda.gov/media/193343/download

BPC-157 translational and formulation barriers — PubMed (NIH)
https://pubmed.ncbi.nlm.nih.gov/42198317/

Suggest a community source

Found a relevant Reddit or forum thread about this compound? Suggest it below. Every suggestion is reviewed by an editor before it appears -- nothing is published automatically.

Related Research Tools

Reconstitution CalculatorConcentration, draw volume, per-unit amounts Unit Convertermg, mcg, mL, units conversion Compound CompareSide-by-side comparison tool Cost CalculatorCost per mg, mcg, per-draw

Research Use Only. All content is for educational and research reference only. Not medical advice, a treatment recommendation, or guidance on human use. Compounds are not FDA-approved drugs unless specifically noted.